Subpart B—Written Recommendations for Investigations of Orphan Drugs
Sections
Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.
Written Recommendations for Investigations of Orphan Drugs
Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.